ConductScience.org, home

Paper39253

Pertussis vaccine--an analysis of benefits, risks and costs.

Koplan JP and 3 others. N Engl J Med, 1979. Cited by 120 papers, by iCite.

Cite this record

ConductScience Library. Pertussis vaccine--an analysis of benefits, risks and costs. Papers, record 39253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39253

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pertussis vaccine--an analysis of benefits, risks and costs.
PubMed
Journal
N Engl J Med
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
120
iCite
Relative citation ratio, by iCite
5.74
iCite
Revised in PubMed
2004-11-17
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Koplan JPJ P
2Schoenbaum SCS C
3Weinstein MCM C
4Fraser DWD W

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cost-Benefit AnalysisMajor topic
National Health ProgramsMajor topic
Pertussis VaccineMajor topic
VaccinationMajor topic
Child
Child, Preschool
Decision Theory
Encephalitis
Encephalomyelitis, Acute Disseminated
Europe
Humans
Infant
Infant, Newborn
Models, Theoretical
Personal Health Services
Risk
United States
Whooping Cough

Source PubMed

Download CSV of topics

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 120 citations.

PMIDTitleJournalYearIn PapersSource
40756762From jurisdiction to veridiction: Expertise and economization of immunization policy in the United States.Econ Soc2025https://conductscience.org/library/papers/40756762PubMed
36919206The incidence, duration, risk factors, and age-based variation of missed opportunities to diagnose pertussis: A population-based cohort study.Infect Control Hosp Epidemiol2023https://conductscience.org/library/papers/36919206PubMed
32918682Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC).Drug Saf2020https://conductscience.org/library/papers/32918682PubMed
29856680Prevention of pertussis: An unresolved problem.Hum Vaccin Immunother2018https://conductscience.org/library/papers/29856680PubMed
2779853120 Years of Public Health Economics and Decision Sciences at the US Centers for Disease Control and Prevention: The CDC Steven M. Teutsch Prevention Effectiveness Fellowship, 1995-2015.J Public Health Manag Pract2017https://conductscience.org/library/papers/27798531PubMed
25747269Pertussis post-exposure prophylaxis among household contacts: a cost-utility analysis.PLoS One2015https://conductscience.org/library/papers/25747269PubMed
24986039Decision-analytic models: current methodological challenges.Pharmacoeconomics2014https://conductscience.org/library/papers/24986039PubMed
21852883Vaccination and the onset of dravet syndrome.Epilepsy Curr2011https://conductscience.org/library/papers/21852883PubMed
20976213Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model.PLoS One2010https://conductscience.org/library/papers/20976213PubMed
18976924Post-vaccination encephalomyelitis: literature review and illustrative case.J Clin Neurosci2008https://conductscience.org/library/papers/18976924PubMed
17619922Transgenic tomatoes express an antigenic polypeptide containing epitopes of the diphtheria, pertussis and tetanus exotoxins, encoded by a synthetic gene.Plant Cell Rep2007https://conductscience.org/library/papers/17619922PubMed
17067190Recent developments in decision-analytic modelling for economic evaluation.Pharmacoeconomics2006https://conductscience.org/library/papers/17067190PubMed
15831828Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.Clin Microbiol Rev2005https://conductscience.org/library/papers/15831828PubMed
11861623The contributions of biomedical informatics to the fight against bioterrorism.J Am Med Inform Assoc2002https://conductscience.org/library/papers/11861623PubMed
11666109Evaluating the benefits of increasing measles immunization rates.Health Serv Res2001https://conductscience.org/library/papers/11666109PubMed
11465300Economic evaluation of a new acellular vaccine for pertussis in Canada.Pharmacoeconomics2001https://conductscience.org/library/papers/11465300PubMed
10885208Fundamentals of clinical economics in health interventions.Indian J Pediatr2000https://conductscience.org/library/papers/10885208PubMed
9625337Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in Germany.Eur J Pediatr1998https://conductscience.org/library/papers/9625337PubMed
8329146Current thoughts on the risks and benefits of immunisation.Drug Saf1993https://conductscience.org/library/papers/8329146PubMed
7262958Strategy for childhood immunization in India. Prioritization of vaccines.Indian J Pediatr1980https://conductscience.org/library/papers/7262958PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39253

GET https://conductscience.org/api/papers/v1/39253/cited_by?page=2